Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for bone fusion in lumbar degenerative disease
NCT01310465Phase 4Unknown
- Sponsor
- Fudan University
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in lumbar intervertebral disc degenerative disease (LDDD), sponsored by Fudan University. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
lumbar intervertebral disc degenerative disease (LDDD)
Beyond the preview
Go deeper on NCT01310465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310465.